Ridgetech, Inc. Reports Fiscal Year 2025 Financial Results

Written by Emily J. Thompson, Senior Investment Analyst

Source: PRnewswire

Updated: Jul 28 2025

0mins

RDGT+11.92%

Should l Buy RDGT?

Source: PRnewswire

Financial Performance Overview: Ridgetech, Inc. reported stable revenue of approximately $120 million for the fiscal year ending March 31, 2025, despite a 3.2% decrease from the previous year. The company achieved a net income of $10.20 million, a significant turnaround from a net loss of $4.23 million in the prior year.
Strategic Business Transformation: The company underwent significant changes, including divesting its retail pharmacy business and acquiring Ridgeline and Allright to enhance its wholesale distribution capabilities in both online and offline markets, reflecting a strategic shift towards the wholesale pharmaceutical sector amidst increasing competition in China's healthcare industry.

Trade with 70% Backtested Accuracy

Stop guessing "Should I Buy RDGT?" and start using high-conviction signals backed by rigorous historical data.

RDGT

$1.69+Infinity%1D

Analyst Views on RDGT

About RDGT

Ridgetech Inc, formerly China Jo-Jo Drugstores Inc, is a retailer and distributor of pharmaceutical and other healthcare products. The Company operates in four business segments. The Retail Drugstores segment sells prescription and over the counter (OTC) medicines, traditional Chinese medicine (TCM), dietary supplements, medical devices, and sundry items to retail customers. The Online Pharmacy segment sells OTC drugs, dietary supplements, medical devices and sundry items through its own and third-party platforms. The Wholesale Business segment includes supplying the Company's own retail drugstores and selling them to other drug vendors and hospitals. The Farming and Selling Herbs segment cultivates selected herbs for sales to other drug vendors.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

Ridgetech, Inc. Reports Fiscal Year 2025 Financial Results

Jul 28 2025PRnewswire

Financial Performance Overview: Ridgetech, Inc. reported stable revenue of approximately $120 million for the fiscal year ending March 31, 2025, despite a 3.2% decrease from the previous year. The company achieved a net income of $10.20 million, a significant turnaround from a net loss of $4.23 million in the prior year.
Strategic Business Transformation: The company underwent significant changes, including divesting its retail pharmacy business and acquiring Ridgeline and Allright to enhance its wholesale distribution capabilities in both online and offline markets, reflecting a strategic shift towards the wholesale pharmaceutical sector amidst increasing competition in China's healthcare industry.

Ridgetech, Inc. Reports Fiscal Year 2025 Financial Results

Jul 28 2025PRnewswire

Financial Performance Overview: Ridgetech, Inc. reported stable revenue of approximately $120 million for the fiscal year ending March 31, 2025, despite a 3.2% decrease from the previous year. The company achieved a net income of $10.20 million, a significant turnaround from a net loss of $4.23 million in the prior year.
Strategic Business Transformation: The company underwent significant changes, including divesting its retail pharmacy business and acquiring Ridgeline and Allright to enhance its wholesale distribution capabilities in both online and offline markets, reflecting a strategic shift towards the wholesale pharmaceutical sector amidst increasing competition in China's healthcare industry.

GET FREE REAL TIME NOTIFICATIONS

Stock Monitor for RDGT?

Get Started Free

FREE STOCK RECOMMENDATIONS DAILY

Stock Bullish Tomorrow

Get Started Free

70% BACKTESTED ACCURACY!

Should I Buy RDGT?

Get Started Free